Gary Sender | CFO |
Theodore Schroeder | CEO & Director |
Jennifer Schranz | Chief Medical Officer |
Ed Arce | H.C. Wainwright & Co. |
Ladies and gentlemen, thank you for standing by, and welcome to the Nabriva Therapeutics Fourth Quarter 2020 Financial Results Call. [Operator Instructions]. I would now like to hand the conference over to your speaker today, Mr. Gary Sender, Chief Financial Officer. The floor is yours.